Search - tctmd.com

Displaying 61 - 80 of 372

Sort: Relevancy | Date

Presentation TCT 2021

AXON Therapeutics

Presenter: Sanjiv Shah

November 06, 2021

Presentation TCT 2021

CVRx - Barostimulation -- CVRx and LivaNova

Presenter: Michael R. Zile

November 06, 2021

Presentation TCT 2021

Interatrial Shunts: Physiological Rationale and Hemodynamic Effects

Presenter: Daniel Burkhoff

November 06, 2021

Presentation TCT 2021

LV Reconstruction II: Bioventrix

Presenter: Gregg Stone

November 06, 2021

Presentation TCT 2021

LV Reconstruction I: Ancora

Presenter: Nadira Hamid

November 06, 2021

Presentation TCT 2021

Overview of Devices for HF: Current and Future Prospects

Presenter: Marat Fudim

November 06, 2021

Presentation TCT 2021

A Validation Study of the OpSens LV Pressure Guidewire

Presenter: Philippe Genereux

November 05, 2021

Presentation TCT 2021

Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)

Presenter: Daniel Burkhoff

November 05, 2021

Presentation TCT 2021

Biventricular Non-Blood Contacting Cardiac Assist Device for Acute Heart Failure Syndrome (CorInnova)

Presenter: William C. Altman

November 05, 2021

Presentation TCT 2021

Implant-less Percutaneous Atrial Shunt-Catheter (PAS-C) System: InterShunt

Presenter: Harlee Sorkin

November 05, 2021

Presentation TCT 2021

Alleviant System: Implant-Free Interatrial Shunt Creation for Heart Failure

Presenter: Jacob Kriegel

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Presenter: Meir Shinnar

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

Presenter: William Abraham

November 05, 2021

News Conference News TCT 2021

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Michael O'Riordan

November 05, 2021

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

Presentation TCT 2021

Changes in Left Ventricular Global Longitudinal Strain in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Stephan Milhorini Pio

November 04, 2021

Presentation TCT 2021

The Role of Heart Failure Optimization Pre- and Post-Procedure

Presenter: Sean Pinney

November 04, 2021

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

Presentation TCT 2021

TCT 539: Use of Percutaneous Intra-aortic Mechanical Circulatory Support to Treat Acute Decompensated Heart Failure With Worsening Renal Function

Presenter: Mir Basir

November 04, 2021

Presentation TCT 2021

V-Sling: Transcatheter Ventricular Repair Devices for Heart Failure Patients (Cardiac Success)

Presenter: Gregg W. Stone

November 04, 2021

Advertisement

AXON Therapeutics

CVRx - Barostimulation -- CVRx and LivaNova

Interatrial Shunts: Physiological Rationale and Hemodynamic Effects

LV Reconstruction II: Bioventrix

LV Reconstruction I: Ancora

Overview of Devices for HF: Current and Future Prospects

A Validation Study of the OpSens LV Pressure Guidewire

Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)

Biventricular Non-Blood Contacting Cardiac Assist Device for Acute Heart Failure Syndrome (CorInnova)

Implant-less Percutaneous Atrial Shunt-Catheter (PAS-C) System: InterShunt

Alleviant System: Implant-Free Interatrial Shunt Creation for Heart Failure

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Changes in Left Ventricular Global Longitudinal Strain in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

The Role of Heart Failure Optimization Pre- and Post-Procedure

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

TCT 539: Use of Percutaneous Intra-aortic Mechanical Circulatory Support to Treat Acute Decompensated Heart Failure With Worsening Renal Function

V-Sling: Transcatheter Ventricular Repair Devices for Heart Failure Patients (Cardiac Success)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content